816f0b486f0ef4a691e8400d62edce590504e873
History.md
| ... | ... | @@ -1,10 +0,0 @@ |
| 1 | - |
|
| 2 | -```mermaid |
|
| 3 | -%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%% |
|
| 4 | -timeline |
|
| 5 | - title Publication timing |
|
| 6 | - 1992-01-01 : Tanaka : DLBCL |
|
| 7 | - 2011-07-27 : Morin : FL |
|
| 8 | - 2021-04-01 : Sarkozy : PMBL |
|
| 9 | - 2022-07-06 : Burkhardt : BL |
|
| 10 | -``` |
|
| ... | ... | \ No newline at end of file |
Overview.md
| ... | ... | @@ -1,5 +0,0 @@ |
| 1 | -## Overview |
|
| 2 | - |
|
| 3 | -BCL2 mutations are frequently found in DLBCL, particularly in the germinal center B-cell (GCB) subtype, and are often located in the flexible loop domain and outside the BCL2-homology domains. |
|
| 4 | -These mutations are caused by the somatic hypermutation process. The presence of these mutations are strongly correlated with the presence of a translocation between BCL2 and one of the immunoglobulin loci. |
|
| 5 | -Although missense mutations may not be under positive selective pressure in the context of lymphomagenesis, some of these mutations may interfere with the function of BCL2 antagonists. |
Template_Relevance.md
| ... | ... | @@ -1,10 +0,0 @@ |
| 1 | - |
|
| 2 | -## Relevance tier by entity |
|
| 3 | - |
|
| 4 | -|Entity|Tier|Description | |
|
| 5 | -|:------:|:----:|--------------------------------------| |
|
| 6 | -| |1[@balSuperenhancerHypermutationAlters2022] |high-confidence DLBCL gene [@tanakaFrequentIncidenceSomatic1992]| |
|
| 7 | -| |1 |high-confidence FL gene| |
|
| 8 | -||2|relevance in PMBL/cHL/GZL not firmly established[@sarkozyMutationalLandscapeGray2021]| |
|
| 9 | -| |2 |relevance in BL not firmly established[@burkhardtClinicalRelevanceMolecular2022]| |
|
| 10 | - | |